CSF3 and deep vein thrombosis: The secondary objectives were to test the association between G-CSF use and brain metastasis free survival and overall survival (OS) and to test for an association between PE/DVT and brain metastasis and G-CSF use in patients with de novo stage IV disease without brain metastasis at the time of diagnosis.